ALISO VIEJO, Calif., Aug. 2, 2011/PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following investor conferences in August.
- Canaccord Genuity Annual Growth Conference
- Location: Intercontinental Hotel, Boston, MA
- Presentation date: Wednesday August 10, 2011
- Presentation time: 10:30am ET
- Wedbush Life Sciences Conference
- Location: Le Parker Meridien, New York, NY
- Presentation date: Tuesday August 16, 2011
- Presentation time: 11:00am ET
A live webcast and 30-day archive of these presentations will be available at http://www.avanir.com.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.
AVANIR is a trademark owned by Avanir Pharmaceuticals, Inc.
©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.
SOURCE Avanir Pharmaceuticals, Inc.
